Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 186   

Articles published

PFE 32.77 -0.02 (-0.06%)
price chart
Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc ...
Heptares Therapeutics ("Heptares"), the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that it has entered into a ...
Sosei Subsidiary Heptares Enters Strategic Drug Discovery Collaboration with ...  Business Wire (press release)
Can Pfizer-Allergan deal benefit Drug Discovery?
Pfizer Inc. (NYSE:PFE) and Allergan PLC agreed to merge last week in an historic deal, the biggest-ever in the drug industry so far.
Editorial: Pfizer's latest discovery: Dodging taxes in Ireland
Why Investors Might Be Undervaluing Allergan  Wall Street Journal (blog)
Pfizer to buy Allergan in $160 billion deal
The acquisition, which would create the world's largest drugmaker and shift Pfizer's headquarters to Ireland, would also be the biggest-ever instance of a U.S.
Pfizer Weighs Splitting Up New Drug Behemoth  Wall Street Journal
Analyst Review on Healthcare Movers: Pfizer Inc. (NYSE:PFE), Johnson & Johnson ...
Pfizer Inc. (NYSE:PFE) showed bullish trend with lower momentum of -0.20% to close at $32.81. The company traded total volume of 16,119,593 shares as compared to its average volume of 39.63 million shares.
Company Shares of Pfizer, Inc. (NYSE:PFE) Rally 1.9%  News Watch International
Pfizer Inc (PFE) Closes 0.03% Up on the Day for November 30
Monday's Vital Data: Apple Inc. (AAPL), Pfizer, Inc. (PFE) and National Bank ...
On the equity options front, Apple Inc. (NASDAQ:AAPL) saw call activity rebound following reports of strong subscriber growth from key Chinese mobile partners China Telecom and China Unicom.
Closing Bell Reports: General Electric Company (GE), Pfizer Inc. (PFE ...  WallStreet Scope
Analyst Target Update: Pfizer, Inc. (NYSE:PFE)
Wall Street brokerages following Pfizer, Inc. (NYSE:PFE) stock have a consensus price target of $41.111 on the name.
Thursday's Vital Data: Apple Inc. (AAPL), Qualcomm, Inc. (QCOM) and Pfizer Inc ...
U.S. stock futures are pointing toward a positive open this morning, as Wall Street feed's on Wednesday's late-session gains.
Sentiment Ratings Released for Pfizer, Inc. (NYSE:PFE)
As per the latest crowd sourced data provided by, a sentiment rating of 3.91 has been given to the share of Pfizer, Inc. (NYSE:PFE). These ratings are represented using a 1 to 5 scale where 5 implies a Buy and 1 a Sell. The ratings helps ...
EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And ...
Bailey continued that Allergan's eyecare and "big cash cow" profile are "attractive." The company also has several next-generation drugs in the pipeline, none of which will become "blockbusters," rather it will offer Pfizer "a bunch of singles and ...
How Pfizer Inc is Ending Hope for Future Inversions  Bidness ETC
5 Things Pfizer Inc. Wants You to Know
Comparatively, Wall Street had been expecting Pfizer to report $600 million less in sales and EPS of only $0.51. It was easily the biggest "beat" we've witnessed from Pfizer in quite some time. However, fixating on a company's top- and bottom-line ...